The Sarah W. Fuller, CW’71, and Samuel Fleming Lecture in Life Sciences & Management was originally established as the Decision Resources Distinguished Lecture, named for the firm Decision Resources (now Clarivate) under the guidance of its co-founders, Samuel C. Fleming, CEO 1989 – 2003, and Sarah W. Fuller, C’71, President 1989 – 2012. As a global leader in providing strategic information to the biopharmaceutical, medical device and health-insurance industries, the firm they founded epitomizes the philosophy behind the LSM program. The University is therefore honored to have the late Sarah Fuller and the late Sam Fleming as the sponsors of this annual lecture series, which brings leaders in the fields of science and business to Penn’s campus.
As founders of this lecture series, Sarah Fuller and Sam Fleming have inspired and will continue to inspire the Vagelos Program in Life Sciences and Management. If it were not for their vision we in Penn and the local community at large would not have what amounts to one of the most memorable public events offered by the program. Sarah and Sam will live on in the hearts and minds of those they have influenced and continue to influence through their legacy.
2022 Fuller-Fleming Lecture:
Dr. Mark V. Pauly
Professor Emeritus of Healthcare Management
The Wharton School, University of Pennsylvania
Is the U.S. Healthcare System Really in Poor Health?
Tuesday, October 25th 6:00PM - 7:30PM
Jon M. Huntsman Hall, 8th Floor, 3730 Walnut Street, Philadelphia
Reception to Follow
Past Fuller-Fleming Lectures:
2019: Jack C. Chow, M.D., M.B.A., M.P.A.
Former U.S. Ambassador, and Distinguished Service Professor
Heinz College of Public Policy, Carnegie Mellon University
The Premise and Promise of Global Health Diplomacy
2018: Lynn M. Schuchter, M.D.
C. Willard Robinson Professor of Hematology-Oncology, Chief of Hematology/Oncology Division, Perelman School of Medicine
Melanoma Program Leader, Abramson Cancer Center of the University of Pennsylvania
More Than Skin Deep: Insights from Melanoma
2017: Ken Frazier, J.D.
Chairman of the Board and CEO, Merck & Co. Inc.
Inventing for Life: Balancing Biomedical Research with the Bottom Line
2016: David Fajgenbaum, M.D., M.B.A., M.Sc.
Co-Founder and Executive Directors of the Castleman Disease Collaborative Network (CDCN)
Research Assistant Professor of Medicine, Division of Translational Medicine & Human Genetics, Perelman School of Medicine, University of Pennsylvania
When Every Second Counts: Using Business Principles to Defeat Castleman Disease
2015: George Yancopoulos, M.D., Ph.D.
Founding Scientist, President, Regeneron Laboratories & Chief Scientific Officer, Regeneron
Building a Better Biotech: The Regeneron Story
2014: Jean Bennett, M.D., Ph.D.
F.M. Kirby Professor of Molecular Opthalmology, Perelman School of Medicine
Seeing is Believing: The Emergence of Rare Disease as a Stepping Stone to Drug Development
2013: Joaquin Duato
Worldwide Chairman, Pharmaceuticals, Johnson & Johnson
Future Forward: New Directions in Meeting Global Health Needs
2012: Paul Offit, M.D.
Chief, Division of Infectious Diseases, Children's Hospital of Pennsylvania, and Maurice R. Hilleman Professor of Vaccinology, University of Pennsylvana School of Medicine
Communicating Science to the Public
2011: Daniel Janzen, Ph.D.
DiMaura Professor of Conservation Biology, University of Pennsylvania, and
Founder, Área de Conservación Guanacaste
Conservation of a Large Tropical Wildland through its Biodiversity Development
2010: Margaret G. McGlynn
Former President of Global Vaccines and Anti-Infectives, Merck & Co., Inc.
Leveraging Science and Business Skills to Impact Global Health
2009: Barry R. Bloom, Ph.D.
Distinguished University Service Professor and Jack and Joan Jacobson Professor of Public Health, Harvard University School of Public Health
The Unfinished Agenda of Infectious Diseases
2008: Philip Needleman, Ph.D.
Former Professor and Chairman, Department of Pharmacology, Washington University Medical School, and Former Chief Scientist and Head of R&D, Monstanto/Searle/Pharmacia
Lessons Learned from Turning a Research Idea into a Drug Used by Millions
2007: Art Caplan, Ph.D.
Emanuel and Robert Hart Professor of Bioethics; Chair, Department of Medical Ethics,
and Director, Center for Bioethics, University of Pennsylvania
A Long and Winding Road: The Evolution of Bioethics from Bedside to Boardroom
2006: Steven A. Nichtberger, M.D.
President and CEO, Tengion, Inc.
Turning Scientific Advances into Transformational Products: Opportunities and Challenges for the Scientist-Business Leader